Croen
HLB bioCode is a South Korea–based preclinical CRO providing GLP-compliant nonclinical testing, PK/TK bioanalysis and assay validation, toxicology and safety pharmacology, histopathology and clinical pathology, ecotoxicology, and one-stop preclinical services for pharmaceutical, biotech, food/cosmetic and chemical companies. The organization operates a GLP research center with dedicated laboratory facilities, QA unit operations, and study management workflows.
Industries
Nr. of Employees
small (1-50)
Services
GLP-compliant safety studies including single- and repeat-dose toxicity in rodents and non-rodents, local toxicity, and regulatory-scope test items.
Method development, validation and quantitative analysis of drugs and metabolites in biological matrices using LC-MS/MS, HPLC and immunoassays for PK/TK and bioavailability studies.
Conduct of bacterial reverse mutation (Ames), in vitro chromosomal aberration and in vivo micronucleus assays to assess genotoxic risk.
Necropsy, tissue processing, slide staining (H&E, IHC, special stains), pathology reading, peer review and clinical pathology assays (hematology, biochemistry, urinalysis).
Cardiovascular telemetry, CNS functional observational batteries, respiratory plethysmography and in vitro cardiac ion-channel (hERG) testing.
Preclinical efficacy testing across multiple disease models including metabolic, oncology, musculoskeletal and ophthalmic systems.
GLP-compliant safety studies including single- and repeat-dose toxicity in rodents and non-rodents, local toxicity, and regulatory-scope test items.
Method development, validation and quantitative analysis of drugs and metabolites in biological matrices using LC-MS/MS, HPLC and immunoassays for PK/TK and bioavailability studies.
Conduct of bacterial reverse mutation (Ames), in vitro chromosomal aberration and in vivo micronucleus assays to assess genotoxic risk.
Necropsy, tissue processing, slide staining (H&E, IHC, special stains), pathology reading, peer review and clinical pathology assays (hematology, biochemistry, urinalysis).
Cardiovascular telemetry, CNS functional observational batteries, respiratory plethysmography and in vitro cardiac ion-channel (hERG) testing.
Preclinical efficacy testing across multiple disease models including metabolic, oncology, musculoskeletal and ophthalmic systems.
Expertise Areas
- Preclinical safety assessment (toxicology)
- PK/TK bioanalysis and assay validation
- Histopathology and clinical pathology
- Safety pharmacology
Key Technologies
- LC-MS/MS
- HPLC
- Triple quadrupole mass spectrometry
- ELISA / immunoassays
News & Updates
Announcement of an MOU collaboration on genetic disease drug development.
Strategic business cooperation MOU announcement.
Knowledge cooperation agreement with an educational institution for companion animal studies.
Announcement of an MOU collaboration on genetic disease drug development.
Strategic business cooperation MOU announcement.
Knowledge cooperation agreement with an educational institution for companion animal studies.